Terms: = Lung cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Diagnosis
18 results:
1. Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell lung cancer.
Abdullah S; Chakraborty R; Kumkar PS; Debnath B; Bala A
J Environ Pathol Toxicol Oncol; 2024; 43(3):13-38. PubMed ID: 38608143
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of Mirna-223-3p Expression in Non-small Cell lung cancers.
Barut Z; Akdeniz FT; Isbir T
Anticancer Res; 2024 Feb; 44(2):585-591. PubMed ID: 38307576
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy of Osimertinib in lung Squamous Cell Carcinoma Patients with
Rekowska A; Rola P; Wójcik-Superczyńska M; Chmielewska I; Krawczyk P; Milanowski J
Curr Oncol; 2022 May; 29(5):3531-3539. PubMed ID: 35621675
[TBL] [Abstract] [Full Text] [Related]
4. The Value of Artificial Intelligence Film Reading System Based on Deep Learning in the diagnosis of Non-Small-Cell lung cancer and the Significance of Efficacy Monitoring: A Retrospective, Clinical, Nonrandomized, Controlled Study.
Chen Y; Tian X; Fan K; Zheng Y; Tian N; Fan K
Comput Math Methods Med; 2022; 2022():2864170. PubMed ID: 35360550
[TBL] [Abstract] [Full Text] [Related]
5. Basaloid Squamous Cell Carcinoma of the Uterine Cervix: Report of a Case With Molecular Analysis.
Munkhdelger J; Shimooka T; Koyama Y; Ikeda S; Mikami Y; Fukuoka J; Hori T; Bychkov A
Int J Surg Pathol; 2021 Oct; 29(7):770-774. PubMed ID: 33792431
[TBL] [Abstract] [Full Text] [Related]
6. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
Min HY; Lee HY
Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Shang Y; Li X; Liu W; Shi X; Yuan S; Huo R; Fang G; Han X; Zhang J; Wang K; Dou Z; Zhang Y; Zang A; Zhang L
Sci Rep; 2020 Nov; 10(1):20243. PubMed ID: 33219256
[TBL] [Abstract] [Full Text] [Related]
8. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.
Jiang N; Zhou J; Zhang W; Li P; Liu Y; Shi H; Zhang C; Wang Y; Zhou C; Peng C; Zhang W; Hao Y; Sun Q; Li Y; Zhao X
Thorac Cancer; 2021 Jan; 12(2):181-193. PubMed ID: 33200540
[TBL] [Abstract] [Full Text] [Related]
9. Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small lung cancer: A Review.
Sławiński G; Wrona A; Dąbrowska-Kugacka A; Raczak G; Lewicka E
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003425
[TBL] [Abstract] [Full Text] [Related]
10. Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.
Herreño AM; Ramírez AC; Chaparro VP; Fernandez MJ; Cañas A; Morantes CF; Moreno OM; Brugés RE; Mejía JA; Bustos FJ; Montecino M; Rojas AP
Tumour Biol; 2019 May; 41(5):1010428319851014. PubMed ID: 31109257
[TBL] [Abstract] [Full Text] [Related]
11. MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK.
Xu L; Xu X; Huang H; Ma Z; Zhang S; Niu P; Chen Y; Ping J; Lu P; Yu C; Min L; Chen J; Dai L; Dong S
Pathol Res Pract; 2018 May; 214(5):776-783. PubMed ID: 29628123
[TBL] [Abstract] [Full Text] [Related]
12. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt T; Magnes T; Hufnagl C; Thorner AR; Ducar M; Neureiter D; Tränkenschuh W; Klieser E; Gaggl A; Rösch S; Rasp G; Hartmann TN; Pleyer L; Rinnerthaler G; Weiss L; Greil R; Egle A
Eur J Cancer; 2018 Apr; 93():69-78. PubMed ID: 29477794
[TBL] [Abstract] [Full Text] [Related]
13. Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.
Hung YP; Lovitch SB; Qian X
Cancer Cytopathol; 2017 Aug; 125(8):604-614. PubMed ID: 28805986
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin.
Yao H; Veine DM; Livant DL
Breast Cancer Res Treat; 2016 Jun; 157(3):489-501. PubMed ID: 27255534
[TBL] [Abstract] [Full Text] [Related]
16. Identifying differentially expressed genes and pathways in two types of non-small cell lung cancer: adenocarcinoma and squamous cell carcinoma.
Liu J; Yang XY; Shi WJ
Genet Mol Res; 2014 Jan; 13(1):95-102. PubMed ID: 24446291
[TBL] [Abstract] [Full Text] [Related]
17. Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status.
Stinchcombe TE; Lee CB; Socinski MA
Clin Lung Cancer; 2006 May; 7 Suppl 4():S111-7. PubMed ID: 16764751
[TBL] [Abstract] [Full Text] [Related]
18. Superior vena cava syndrome.
Bilyeu JA
J Insur Med; 2001; 33(4):349-52. PubMed ID: 11877915
[TBL] [Abstract] [Full Text] [Related]
